Recherche, publications, enseignements

Recherche,
publications,
enseignements
Enseignement
Enseignement Universitaire
Enseignement
de
l’Urologie
aux
étudiants de 3e et 4e années de médecine à l’Université
Paris-Descartes (lien)
Enseignement à l’Ecole Européenne de chirurgie
Enseignement en Master de Santé à la Faculté de Droit –
Université Paris-Descartes
Accueil et Enseignement des Internes en
Urologie
Le département est validant pour le Certificat d’Etudes
Supérieures d’Urologie. Il accueille deux internes français et
3 à 4 résidents internationaux (fellows) par semestre.
Le département a notamment développé plusieurs « fellowship »
en partenariat avec des Universités aux Etast-Unis, en
Amérique du Sud, en Europe, en Asie et en Afrique.
Pour plus de renseignements, contactez la responsable du
secrétariat [email protected]
Accueil et Enseignement des Etudiants
hospitaliers
3 postes d’externes sont disponibles à l’année. Pour plus de
renseignements, contacter la faculté de médecine Université
Paris Descartes (lien)
Accueil et Enseignement
Internationaux
d’Urologues
Le département accueille des visiteurs étrangers pour une
durée variable. Pour plus de renseignements, contactez la
responsable du secrétariat [email protected]
Recherche
Le Département d’Urologie participe à de nombreux protocoles
et travaux de recherche.
Il travaille notamment en étroite collaboration avec le
Centre de Recherche des Cordeliers (lien) (Unité INSERM
872, Rue de l’Ecole de Médecine) dans le domaine du
« Micro-environnement Immunitaire et de la Génomique des
cancers urologiques »
Le Département d’Urologie est investigateur principal ou
co-investigateur de nombreux protocoles de recherche en
Urologie, notamment en Cancérologie.
L’équipe encadre et coordonne aussi régulièrement des
travaux de thèse et de mémoires.
Publications
Livres
La prostate après 40 ans
Guy Vallancien ; Ed. Privat 2007
Hypertrophie Bénigne de Prostate : Paroles de Patients
Xavier Cathelineau ; Ed. Phase 5 2007
La Révolution Médicale
Jean Pierre Davant, Thomas Tursz, Guy Vallancien ; avec Pierre
Boncenne
Ed. Seuil 2003
Troubles urinaires de l’adulte
Xavier Cathelineau, Guy Vallancien ; Ed. Masson 2001
Chapitres de Livres
“Robotic versus standard laparoscopic prostatectomy”
Ed Saunders, 2008
F.Rozet, X.Cathelineau, E.Barret, G.Vallancien
“Robotic radical prostatectomy : the apical dissection”
Robotic Urology, Ed Springer, 2007
X.Cathelineau, E.Barret; F.Rozet, G.Vallancien
“Prostatectomia radical laparoscopica”
Curso audiovisual de nuevas tecnologias en urologia,
Ed EAU, 2005
X.Cathelineau, F.Rozet, E.Barret, G.Vallancien
“Laparoscopic radical prostatectomy”
Urologic Oncology Ed Elsevier, 2005
G.Vallancien, X.Cathelineau
“Robotic radical prostatectomy: the European experience”
Robotic Urologic Surgery,Urologic Clinics of North America,
Ed Elsevier, 2004
X Cathelineau, F.Rozet, G.Vallancien
“ Telerobotic-assisted prostatectomy”
Primer of robotics and telerobotics surgery,
Ed Lippincott Williams, 2004
X.Cathelineau, F.Rozet, G.Vallancien
“Laparoscopic radical prostatectomy”
Hot Topics in Urology, Ed Saunders 2004
X.Cathelineau, G.Vallancien
“New surgical techniques”
Prostate Cancer International Consultation
Ed L.Denis, S Khoury, 2003
G. Vallancien, X.Cathelineau
Articles- Publications
Focal therapy in prostate cancer: the current situation.
Jácome-Pita F, Sánchez-Salas R, Barret E, Amaruch N, GonzalezEnguita C, Cathelineau X.
Ecancermedicalscience. 2014 Jun 10;8:435. eCollection 2014.
Influence of preoperative factors on the oncologic outcome for
upper urinary tract urothelial carcinoma after radical
nephroureterectomy.
Hurel S, Rouprêt M, Seisen T, Comperat E, Phé V, Droupy S,
Audenet F, Pignot G, Cathelineau X, Guy L, Cussenot O, Ouzzane
A, Bozzini G, Nison L, Ruffion A, Colin P.
World J Urol. 2014 May 9.
How to diagnose and treat focal therapy failure and
recurrence?
Barret E, Harvey-Bryan KA, Sanchez-Salas R, Rozet F, Galiano
M, Cathelineau X.
Curr Opin Urol. 2014 May;24(3):241-6.
Reply to Gianluca Giannarini, Nazareno Suardi and Alberto
Briganti’s letter to the editor re: Prasanna Sooriakumaran,
Abhishek Srivastava, Shahrokh F. Shariat, et al. A
multinational, multi-institutional study comparing positive
surgical margin rates among 22 393 open, laparoscopic, and
robot-assisted radical prostatectomy patients. Eur Urol. In
press. http://dx.doi.org/10.1016/j.eururo.2013.11.018.
Sooriakumaran P, Wiklund P, Roobol MJ, Steyerberg E, Sanchez-
Salas R, Cathelineau X, Tewari AK.
Eur Urol. 2014 Jun;65(6):e91-2.
Expression patterns of candidate susceptibility genes HNF1β
and CtBP2 in prostate cancer: association with tumor
progression.
Debiais-Delpech C, Godet J, Pedretti N, Bernard FX, Irani J,
Cathelineau X, Cussenot O, Fromont G.
Urol Oncol. 2014 May;32(4):426-32.
A Multinational, Multi-institutional Study Comparing Positive
Surgical Margin Rates Among 22393 Open, Laparoscopic, and
Robot-assisted Radical Prostatectomy Patients.
Sooriakumaran P, Srivastava A, Shariat SF, Stricker PD,
Ahlering T, Eden CG, Wiklund PN, Sanchez-Salas R, Mottrie A,
Lee D, Neal DE, Ghavamian R, Nyirady P, Nilsson A, Carlsson S,
Xylinas E, Loidl W, Seitz C, Schramek P, Roehrborn C,
Cathelineau X, Skarecky D, Shaw G, Warren A, Delprado WJ,
Haynes AM, Steyerberg E, Roobol MJ, Tewari AK.
Eur Urol. 2013 Nov 24. pii: S0302-2838(13)01215-3.
Focal cryoablation: a treatment option for unilateral low-risk
prostate cancer.
Durand M, Barret E, Galiano M, Rozet F, Sanchez-Salas R,
Ahallal Y, Macek P, Gaya JM, Cerruti J, Devilliers H, Loeffler
J, Amiel J, Vallancien G, Cathelineau X.
BJU Int. 2014 Jan;113(1):56-64.
Transcorporal artificial urinary sphincter implantation as a
salvage surgical procedure for challenging cases of male
stress urinary incontinence: surgical technique and functional
outcomes in a contemporary series.
Wiedemann L, Cornu JN, Haab E, Peyrat L, Beley S, Cathelineau
X, Haab F.
BJU Int. 2013 Dec;112(8):1163-8.
Prostate histoscanning in clinically localized biopsy proven
prostate cancer: an accuracy study.
Macek P, Barret E, Sanchez-Salas R, Galiano M, Rozet F,
Ahallal Y, Gaya JM, Durant M, Mascle L, Giedelman C, Lunelli
L, Validire P, Nesvadba M, Cathelineau X.
J Endourol. 2014 Mar;28(3):371-6.
Impact of micropapillary histological variant on survival
after radical nephroureterectomy for upper tract urothelial
carcinoma.
Masson-Lecomte A, Colin P, Bozzini G, Nison L, de La Taille A,
Comperat E, Zerbib M, Rozet F, Cathelineau X, Valeri A,
Ruffion A, Guy L, Droupy S, Cussenot O, Rouprêt M.
World J Urol. 2014 Apr;32(2):531-7.
Positive surgical margins after minimally invasive radical
prostatectomy in patients with pT2 and pT3a disease could be
considered pathological upstaging.
Ouzzane A, Rozet F, Salas RS, Galiano M, Barret E, Prapotnich
D, Cathelineau X.
BJU Int. 2014 Apr;113(4):586-91.
Oncologic outcomes after minimally invasive radical
prostatectomy in patients with seminal vesicle invasion (pT3b)
without adjuvant therapy.
Forgues A, Rozet F, Audenet F, Ouzzane A, Sanchez-Salas R,
Barret E, Galiano M, Prapotnich D, Cathelineau X.
World J Urol. 2014 Apr;32(2):519-24.
Current, new and novel therapy for castration-resistant
prostate cancer.
Gaya JM, Ahallal Y, Sanchez-Salas R, Barret E, Rozet F,
Galiano M, Macek P, Durand M, Cerruti J, Prapotnich D, Ropert
S, Bennamoun M, Cathelineau X.
Expert Rev Anticancer Ther. 2013 Jul;13(7):819-27.
Accurate patient selection and multimodal treatment offer the
best therapeutic option in high-risk prostate cancer.
Rozet F, Audenet F, Sanchez-Salas R, Galiano M, Barret E,
Cathelineau X.
Expert Rev Anticancer Ther. 2013 Jul;13(7):811-8.
Risk stratification of metastatic recurrence in invasive upper
urinary tract carcinoma after radical nephroureterectomy
without lymphadenectomy.
Colin P, Ghoneim TP, Nison L, Seisen T, Lechevallier E,
Cathelineau X, Ouzzane A, Zerbib M, Long JA, Ruffion A,
Crouzet S, Cussenot O, Audouin M, Irani J, Gardic S, Gres P,
Audenet F, Roumiguié M, Valeri A, Rouprêt M.
World J Urol. 2014 Apr;32(2):507-12.
Prostate-sparing radical cystectomy for selected patients with
bladder cancer.
Macek P, Sanchez-Salas R, Rozet F, Barret E, Galiano M, Hanus
T, Cathelineau X.
Urol Int. 2013;91(1):89-96
The Impact of Robotic Surgery in Urology.
Giedelman CA, Abdul-Muhsin H, Schatloff O, Palmer K, Lee L,
Sanchez-Salas R, Cathelineau X, Dávila H, Cavelier L, Rueda M,
Patel V.
Actas Urol Esp. 2013 Nov-Dec;37(10):652-7
Focal brachytherapy for selected low-risk prostate cancers: A
pilot study.
Cosset JM, Cathelineau X, Wakil G, Pierrat N, Quenzer O,
Prapotnich D, Barret E, Rozet F, Galiano M, Vallancien G.
Brachytherapy. 2013 Apr 16.
8q24 amplification is associated with Myc expression and
prostate cancer progression and is an independent predictor of
recurrence after radical prostatectomy.
Fromont G, Godet J, Peyret A, Irani J, Celhay O, Rozet F,
Cathelineau X, Cussenot O.
Hum Pathol. 2013 Apr 8.
Expression screening of cancer/testis genes in prostate cancer
identifies nr6a1 as a novel marker of disease progression and
aggressiveness.
Mathieu R, Evrard B, Fromont G, Rioux-Leclercq N, Godet J,
Cathelineau X, Guillé F, Primig M, Chalmel F.
Prostate. 2013 Mar 26.
Renal biopsies for small renal masses. For whom, when and how.
Stakhovsky O, Sanchez-Salas R, Barret E, Yap SA, Finelli A,
Rozet F, Galiano M, Lenoir S, Strauss C, Validire P,
Cathelineau X.
Arch Esp Urol. 2013 Jan-Feb;66(1):4-15.
Morbidity of focal therapy in the treatment of localized
prostate cancer.
Barret E, Ahallal Y, Sanchez-Salas R, Galiano M, Cosset JM,
Validire P, Macek P, Durand M, Prapotnich D, Rozet F,
Cathelineau X.
Eur Urol. 2013 Apr;63(4):618-22.
Oncologic outcomes after laparoscopic partial nephrectomy:
mid-term results.
Favaretto RL, Sanchez-Salas R, Benoist N, Ercolani M, Forgues
A, Galiano M, Rozet F, Prapotnich D, Barret E, Cathelineau X.
J Endourol. 2013 Jan;27(1):52-7.
High-intensity focused ultrasound
treatment of prostate cancer.
(HIFU)
for
definitive
Cordeiro ER, Cathelineau X, Thüroff S, Marberger M, Crouzet S,
de la Rosette JJ.
BJU Int. 2012 Nov;110(9):1228-42.
BCAR1 expression improves prediction of biochemical reccurence
after radical prostatectomy.
Fromont G, Rozet F, Cathelineau X, Ouzzane A, Doucet L,
Fournier G, Cussenot O.
Prostate. 2012 Sep 1;72(12):1359-65.
Technology development for laparo-endoscopic single site
surgery: from Keypoint to QuadPort+.
Sanchez-Salas R, Barret E, Cathelineau X.
Future Oncol. 2011 Dec;7(12):1365-7.
[Management of primary carcinoma of the seminal vesicle].
Favaretto RL, Ercolani MC, Sánchez-Salas R, Validire P, Barret
E, Cathelineau X.
Actas Urol Esp. 2012 Jan;36(1):67-8.
[Robotic surgery: history and teaching impact].
Valero R, Ko YH, Chauhan S, Schatloff O, Sivaraman A, Coelho
RF, Ortega F, Palmer KJ, Sanchez-Salas R, Davila H,
Cathelineau X, Patel VR.
Actas Urol Esp. 2011 Oct;35(9):540-5.
Robotic-assisted laparoendoscopic single-site surgery (R-LESS)
in urology: an evidence-based analysis.
Barret E, Sanchez-Salas R, Ercolani M, Forgues A, Rozet F,
Galiano M, Cathelineau X.
Minerva Urol Nefrol. 2011 Jun;63(2):115-22. Review.
Focal therapy with high-intensity focused ultrasound for
prostate cancer in the elderly. A feasibility study with 10
years follow-up.
El Fegoun AB, Barret E, Prapotnich D, Soon S, Cathelineau X,
Rozet F, Galiano M, Sanchez-Salas R, Vallancien G.
Int Braz J Urol. 2011 Mar-Apr;37(2):213-9; discussion 220-2.
Natural orifice transendoluminal surgery and laparoendoscopic
single-site surgery: the future of laparoscopic radical
prostatectomy.
Barret E, Sanchez-Salas R, Ercolani MC, Rozet F, Galiano M,
Cathelineau X.
Future Oncol. 2011 Mar;7(3):427-34.
Comparison of the rate, location and size of positive surgical
margins after laparoscopic and robot-assisted laparoscopic
radical prostatectomy.
Kasraeian A, Barret E, Chan J, Sanchez-Salas R, Validire P,
Cathelineau X, Rozet F, Galiano M, Vallancien G.
BJU Int. 2011 Oct;108(7):1174-8.
One-step customized transurethral resection of the prostate
and permanent implant brachytherapy for selected prostate
cancer patients: Technically feasible but too toxic.
Cosset JM, Barret E, Castro-Pena P, Cathelineau X, Galiano M,
Rozet F, Pierrat N, Timbert M, Vallancien G.
Brachytherapy. 2011 Jan-Feb;10(1):29-34.